| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/22/2001 | WO2001019795A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | WO2001019542A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | WO2001019410A2 Human flash and uses thereof |
| 03/22/2001 | WO2001019399A2 Method of potentiating chemotherapy and treating solid tumors |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019396A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 03/22/2001 | WO2001019393A1 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems |
| 03/22/2001 | WO2001019392A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 03/22/2001 | WO2001019391A1 Topical treatment of streptococcal infections |
| 03/22/2001 | WO2001019390A1 Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
| 03/22/2001 | WO2001019389A1 Remedies for rheumatoid arthritis and fused protein |
| 03/22/2001 | WO2001019388A1 Medicament containing contactinhibin and medicament containing antibodies directed against contactinhibin |
| 03/22/2001 | WO2001019387A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | WO2001019386A2 Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 03/22/2001 | WO2001019385A2 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 03/22/2001 | WO2001019384A2 Ant-1 as drug target |
| 03/22/2001 | WO2001019380A2 Oncolytic virus |
| 03/22/2001 | WO2001019379A2 Methods for treating muscular dystrophy with bone marrow cells |
| 03/22/2001 | WO2001019353A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | WO2001019347A1 Vascular coating composition |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001019338A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | WO2001019331A1 Skin care product containing a catalase |
| 03/22/2001 | WO2001019305A1 Water absorbent keratin and gel formed therefrom |
| 03/22/2001 | WO2001019186A1 Composition and method for treating wounds |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | WO2001008695A3 Use of amh and/or amh agonists and/or amh antagonists for long-term control of female fertility |
| 03/22/2001 | WO2001006843A3 Promotion of proliferation of adult corneal endothelial cells |
| 03/22/2001 | WO2001005435A3 Antisense therapy for hormone-regulated tumors |
| 03/22/2001 | WO2001001749A3 FVIIa ANTAGONISTS |
| 03/22/2001 | WO2001000814A3 Hetero-associating coiled-coil peptides and screenign method therefor |
| 03/22/2001 | WO2001000811A3 17867, a novel human aminopeptidase |
| 03/22/2001 | WO2000078793A3 Antimicrobial agents |
| 03/22/2001 | WO2000078341A8 A method for the prophylaxis and/or treatment of medical disorders |
| 03/22/2001 | WO2000074629A3 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000071567A3 Fibroblast growth factor 13 |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000067782A3 Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent |
| 03/22/2001 | WO2000063240A9 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE) |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000052037A8 Echinocandin/carbohydrate complexes |
| 03/22/2001 | WO2000046245A8 Human antibiotic proteins |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000035469A9 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER |
| 03/22/2001 | WO2000030672A9 Collagen based biomaterials and methods of preparation and use |
| 03/22/2001 | WO2000029443A9 Contraceptive antibody vaccines |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | WO1999050414A9 Blk genes, gene products and uses thereof in apoptosis |
| 03/22/2001 | DE19944404A1 Mittel zur Therapie von menschlichen Erkrankungen, insbesondere für die Therapie von Tumoren wie Kolonkarzinomen und Melanomen oder zur Geweberegeneration und Förderung des Haarwuchses Means for therapy of human disease, in particular for the treatment of tumors such as colon carcinoma and melanoma, or for tissue regeneration and promote hair growth |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | DE10031122A1 Composition for the treatment of malignant diseases comprises agents that reduce concentration of YB-1 protein or inhibit its translocation in tumor cells |
| 03/22/2001 | CA2388383A1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | CA2386559A1 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2385234A1 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | CA2385063A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | CA2384991A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | CA2384881A1 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 03/22/2001 | CA2384861A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 03/22/2001 | CA2384768A1 Methods and compositions for preserving chondrocytes and uses |
| 03/22/2001 | CA2384766A1 Subunit optimized fusion proteins |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384247A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | CA2384135A1 Dipeptidyl peptidases |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
| 03/22/2001 | CA2383402A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | CA2383217A1 Lysosomal targeting pathway enzymes |
| 03/22/2001 | CA2383184A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2383038A1 Topical treatment of streptococcal infections |
| 03/22/2001 | CA2383026A1 Combination treatment with il-1ra and compounds that inhibit il-1 processing and release |
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/22/2001 | CA2382544A1 Methods of peptide preparation |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/22/2001 | CA2381078A1 Method of potentiating chemotherapy and treating solid tumors |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/21/2001 | EP1085092A1 Phosphodiesterase enzymes |
| 03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
| 03/21/2001 | EP1085084A1 Chondrocytes compositions, preparation and use |
| 03/21/2001 | EP1085082A1 Methods and compositions for chondrocytes preservation and uses therefor |
| 03/21/2001 | EP1084719A1 Bone sialoprotein-based compositions for enhancing connective tissue repair |
| 03/21/2001 | EP1084718A1 Endothelin-based compositions for enhancing connective tissue repair |
| 03/21/2001 | EP1084717A1 Pleiotrophin-based compositions for enhancing connective tissue repair |
| 03/21/2001 | EP1084705A2 Method for lowering blood glucose levels in mammals |